Eiji Kurosaki Selected Research

Eiji Kurosaki Research Topics

Disease

13	Type 2 Diabetes Mellitus (MODY) 08/2017 - 11/2006
12	Hyperglycemia 01/2018 - 03/2003
7	Insulin Resistance 07/2016 - 06/2006
6	Obesity 01/2018 - 06/2006
4	Inflammation (Inflammations) 08/2017 - 09/2013
4	Glucose Intolerance 09/2013 - 07/2002
3	Body Weight (Weight, Body) 01/2017 - 07/2013
3	Hypoglycemia (Reactive Hypoglycemia) 07/2013 - 01/2012
2	Hyperinsulinism (Hyperinsulinemia) 01/2018 - 09/2013
2	Albuminuria 07/2014 - 11/2006
2	Hyperlipidemias (Hyperlipidemia) 09/2013 - 11/2006
1	Fatty Liver 08/2017
1	Diabetes Complications 08/2017
1	Overweight 01/2017
1	Non-alcoholic Fatty Liver Disease 05/2015
1	Fibrosis (Cirrhosis) 05/2015
1	Liver Cirrhosis (Hepatic Cirrhosis) 05/2015
1	Metabolic Diseases (Metabolic Disease) 05/2015
1	Diabetes Mellitus 01/2015
1	Type 1 Diabetes Mellitus (Autoimmune Diabetes) 07/2014
1	Weight Loss (Weight Reduction) 03/2014
1	Metabolic Syndrome (Dysmetabolic Syndrome X) 09/2013
1	Diabetic Nephropathies (Diabetic Nephropathy) 11/2006
1	Proteinuria 11/2006

Drug/Important Bio-Agent (IBA)

15	Glucose (Dextrose)FDA LinkGeneric 01/2018 - 07/2002
14	ipragliflozinIBA 01/2018 - 01/2012
8	Sodium-Glucose Transporter 2 InhibitorsIBA 08/2017 - 05/2012
6	Sodium-Glucose Transport ProteinsIBA 01/2017 - 01/2012
5	Hypoglycemic Agents (Hypoglycemics)IBA 01/2017 - 08/2006
4	Insulin (Novolin)FDA Link 09/2013 - 08/2006
4	YM 440IBA 11/2006 - 07/2002
3	SodiumIBA 01/2015 - 05/2012
3	Streptozocin (Streptozotocin)FDA Link 07/2014 - 01/2012
2	dapagliflozinIBA 08/2017 - 07/2016
2	Choline (Choline Chloride)IBA 05/2015 - 07/2013
2	Blood Glucose (Blood Sugar)IBA 01/2015 - 09/2013
2	Niacinamide (Nicotinamide)FDA LinkGeneric 09/2013 - 01/2012
2	GlucosidesIBA 07/2013 - 05/2012
2	PPAR gammaIBA 06/2006 - 03/2003
1	empagliflozinIBA 08/2017
1	1,5- anhydro- 1- (5- (4- ethoxybenzyl)- 2- methoxy- 4- methylphenyl)- 1- thioglucitolIBA 08/2017
1	CanagliflozinIBA 08/2017
1	6- ((4- ethylphenyl)methyl)- 3',4',5',6'- tetrahydro- 6'- (hydroxymethyl)spiro(isobenzofuran- 1(3H),2'- (2H)pyran)- 3',4',5'- triolIBA 08/2017
1	Hemoglobins (Hemoglobin)IBA 01/2017
1	CDAA (Randox)IBA 05/2015
1	Pioglitazone (Actos)FDA Link 05/2015
1	Amino Acids FDA Link 05/2015
1	Hydroxyproline (4 Hydroxyproline)IBA 05/2015
1	Triglycerides (Triacylglycerol)IBA 05/2015
1	Angiotensin II Type 1 Receptor BlockersIBA 04/2014
1	Therapeutic UsesIBA 09/2013
1	azuleneIBA 07/2013
1	Biological ProductsIBA 07/2013
1	SaltsIBA 07/2013
1	SymportersIBA 05/2012
1	benzothiopheneIBA 05/2012
1	LigandsIBA 06/2006
1	Anti-Obesity Agents (Antiobesity Drugs)IBA 06/2006
1	2-chloro-5-nitrobenzanilideIBA 06/2006
1	GlycogenIBA 07/2002

Therapy/Procedure

2	Glycemic Control 03/2016 - 01/2015
1	Oral Administration 08/2013